BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18785890)

  • 1. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.
    Rubio C; Martin MA; Arranz Sánchez DM; Vidaurrazaga C; Casado M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):707-8. PubMed ID: 18785890
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade).
    Mang R; Ruzicka T; Stege H
    Br J Dermatol; 2004 Feb; 150(2):379-80. PubMed ID: 14996123
    [No Abstract]   [Full Text] [Related]  

  • 3. Three years' experience with infliximab in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Clin Exp Dermatol; 2006 Sep; 31(5):630-3. PubMed ID: 16901301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol.
    Emtestam L; Wedén U
    Br J Dermatol; 1996 Oct; 135(4):644-6. PubMed ID: 8915165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab.
    Milani-Nejad N; Kaffenberger J
    J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.
    Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C
    Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153
    [No Abstract]   [Full Text] [Related]  

  • 11. Recalcitrant acrodermatitis continua of hallopeau treated with calcitriol and tacrolimus 0.1% topical treatment.
    Brunasso AM; Lo Scocco G; Massone C
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1272-3. PubMed ID: 18422537
    [No Abstract]   [Full Text] [Related]  

  • 12. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
    Adışen E; Özer İ; Temel B; Gürer MA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrodermatitis continua of Hallopeau responding to efalizumab therapy.
    Balato N; Gallo L; Balato A; La Bella S; Ayala F
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1329-30. PubMed ID: 19250321
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uselessness of topical calcipotriol as monotherapy for acrodermatitis continua of Hallopeau.
    Kokelj F; Plozzer C; Trevisan G
    Acta Derm Venereol; 2001 May; 81(2):153. PubMed ID: 11501664
    [No Abstract]   [Full Text] [Related]  

  • 17. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis continua of Hallopeau: evolution of treatment options.
    Sehgal VN; Verma P; Sharma S; Srivastava G; Aggarwal AK; Rasool F; Chatterjee K
    Int J Dermatol; 2011 Oct; 50(10):1195-211. PubMed ID: 21950286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effect of topical calcipotriol in acrodermatitis continua of hallopeau.
    Mozzanica N; Cattaneo A
    Br J Dermatol; 1998 Mar; 138(3):556. PubMed ID: 9580829
    [No Abstract]   [Full Text] [Related]  

  • 20. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy.
    Kiszewski AE; De Villa D; Scheibel I; Ricachnevsky N
    Pediatr Dermatol; 2009; 26(1):105-6. PubMed ID: 19250426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.